Veterinary Pharmaceutical Solutions

The firm operates under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits licensed pharmacists to compound drugs for individual patients on a prescription basis. State pharmacy boards provide the primary day-to-day oversight, while FDA holds enforcement authority against compounders that venture into manufacturing or produce unapproved copies of commercial animal drugs. The Animal Medicinal Drug Use Clarification Act of 1994 further shapes the firm's scope by defining when compounded medications can be used in food-producing animals.

No. The firm compounds existing FDA-approved active pharmaceutical ingredients into customized dosage forms — it does not sponsor new animal drug applications, conduct clinical trials, or hold patents. This positions it as a service provider to veterinary clinics, not a research-and-development enterprise.

Comparable animal-health compounders include Wedgewood Pharmacy, Stokes Pharmacy, and Epicur Pharma — all of which have received private-equity investment and maintain a public profile. Veterinary Pharmaceutical Solutions has not disclosed any investment partner, and its absence from trade publications suggests a smaller, possibly regional footprint within the highly fragmented compounding sector.

No FDA warning letters, recalls, or state board actions were identified in public records for this entity. The agency has, however, actively targeted animal-drug compounders for marketing unapproved copies of commercial products — a risk facing all firms in this space, whether or not they have been cited to date.

503A compounders produce medications for individual patient prescriptions under pharmacist supervision — this is the model most veterinary compounders follow. 503B outsourcing facilities can produce larger batches and sell to veterinary practices for office stock, but they must comply with current good manufacturing practices and FDA inspections. Veterinary Pharmaceutical Solutions, like most independent compounding pharmacies, almost certainly operates under the 503A framework.